Cargando…
Challenges and Solutions in Oral Isotretinoin in Acne: Reflections on 35 Years of Experience
Acne vulgaris affects more than 80% of adolescents and young adults and forms a substantial proportion of the dermatologist’s and general practitioner’s caseload. Severity of symptoms varies but may result in facial scarring and psychological repercussions. Oral isotretinoin is highly effective but...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951028/ https://www.ncbi.nlm.nih.gov/pubmed/32021364 http://dx.doi.org/10.2147/CCID.S234231 |
_version_ | 1783486205576347648 |
---|---|
author | Bettoli, Vincenzo Guerra-Tapia, Aurora Herane, Maria Isabel Piquero-Martín, Jaime |
author_facet | Bettoli, Vincenzo Guerra-Tapia, Aurora Herane, Maria Isabel Piquero-Martín, Jaime |
author_sort | Bettoli, Vincenzo |
collection | PubMed |
description | Acne vulgaris affects more than 80% of adolescents and young adults and forms a substantial proportion of the dermatologist’s and general practitioner’s caseload. Severity of symptoms varies but may result in facial scarring and psychological repercussions. Oral isotretinoin is highly effective but can only be prescribed by specialists. Side effects are recognized and mostly predictable, ranging from cosmetic effects to teratogenicity. These can affect patients’ quality of life and treatment adherence. This article provides a commentary on 4 key areas: the use of oral isotretinoin vs oral antibiotics, including the importance of early recognition of nonresponse to treatment, the psychological effects of acne and isotretinoin treatment, the side effects of isotretinoin therapy, and cosmetic treatment options that can help alleviate predictable side effects. The authors, who have all participated in various international expert groups, draw on relevant literature and their extensive professional experience with oral isotretinoin in the treatment of acne. The aim of this article is to provide an informative and practical approach to managing oral isotretinoin treatment in patients with acne, to help optimize treatment of this skin disease. |
format | Online Article Text |
id | pubmed-6951028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-69510282020-02-04 Challenges and Solutions in Oral Isotretinoin in Acne: Reflections on 35 Years of Experience Bettoli, Vincenzo Guerra-Tapia, Aurora Herane, Maria Isabel Piquero-Martín, Jaime Clin Cosmet Investig Dermatol Expert Opinion Acne vulgaris affects more than 80% of adolescents and young adults and forms a substantial proportion of the dermatologist’s and general practitioner’s caseload. Severity of symptoms varies but may result in facial scarring and psychological repercussions. Oral isotretinoin is highly effective but can only be prescribed by specialists. Side effects are recognized and mostly predictable, ranging from cosmetic effects to teratogenicity. These can affect patients’ quality of life and treatment adherence. This article provides a commentary on 4 key areas: the use of oral isotretinoin vs oral antibiotics, including the importance of early recognition of nonresponse to treatment, the psychological effects of acne and isotretinoin treatment, the side effects of isotretinoin therapy, and cosmetic treatment options that can help alleviate predictable side effects. The authors, who have all participated in various international expert groups, draw on relevant literature and their extensive professional experience with oral isotretinoin in the treatment of acne. The aim of this article is to provide an informative and practical approach to managing oral isotretinoin treatment in patients with acne, to help optimize treatment of this skin disease. Dove 2019-12-30 /pmc/articles/PMC6951028/ /pubmed/32021364 http://dx.doi.org/10.2147/CCID.S234231 Text en © 2019 Bettoli et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Expert Opinion Bettoli, Vincenzo Guerra-Tapia, Aurora Herane, Maria Isabel Piquero-Martín, Jaime Challenges and Solutions in Oral Isotretinoin in Acne: Reflections on 35 Years of Experience |
title | Challenges and Solutions in Oral Isotretinoin in Acne: Reflections on 35 Years of Experience |
title_full | Challenges and Solutions in Oral Isotretinoin in Acne: Reflections on 35 Years of Experience |
title_fullStr | Challenges and Solutions in Oral Isotretinoin in Acne: Reflections on 35 Years of Experience |
title_full_unstemmed | Challenges and Solutions in Oral Isotretinoin in Acne: Reflections on 35 Years of Experience |
title_short | Challenges and Solutions in Oral Isotretinoin in Acne: Reflections on 35 Years of Experience |
title_sort | challenges and solutions in oral isotretinoin in acne: reflections on 35 years of experience |
topic | Expert Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951028/ https://www.ncbi.nlm.nih.gov/pubmed/32021364 http://dx.doi.org/10.2147/CCID.S234231 |
work_keys_str_mv | AT bettolivincenzo challengesandsolutionsinoralisotretinoininacnereflectionson35yearsofexperience AT guerratapiaaurora challengesandsolutionsinoralisotretinoininacnereflectionson35yearsofexperience AT heranemariaisabel challengesandsolutionsinoralisotretinoininacnereflectionson35yearsofexperience AT piqueromartinjaime challengesandsolutionsinoralisotretinoininacnereflectionson35yearsofexperience |